Waxman J - Search Results

1

Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer.

Michalaki V, Syrigos K, Charles P, Waxman J. Michalaki V, et al. Among authors: waxman j. Br J Cancer. 2004 Jun 14;90(12):2312-6. doi: 10.1038/sj.bjc.6601814. Br J Cancer. 2004. PMID: 15150588 Free PMC article.

2

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells.

Ottaviani S, Brooke GN, O'Hanlon-Brown C, Waxman J, Ali S, Buluwela L. Ottaviani S, et al. Among authors: waxman j. J Mol Endocrinol. 2013 Nov 7;51(3):301-12. doi: 10.1530/JME-13-0169. Print 2013 Dec. J Mol Endocrinol. 2013. PMID: 23997240 Free PMC article.

3

Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.

Darrington RS, Campa VM, Walker MM, Bengoa-Vergniory N, Gorrono-Etxebarria I, Uysal-Onganer P, Kawano Y, Waxman J, Kypta RM. Darrington RS, et al. Among authors: waxman j. Int J Cancer. 2012 Sep 15;131(6):E872-83. doi: 10.1002/ijc.27620. Epub 2012 May 22. Int J Cancer. 2012. PMID: 22539113

4

Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.

Pchejetski D, Böhler T, Stebbing J, Waxman J. Pchejetski D, et al. Among authors: waxman j. Nat Rev Urol. 2011 Sep 13;8(10):569-678. doi: 10.1038/nrurol.2011.117. Nat Rev Urol. 2011. PMID: 21912422 Review.

5

Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer.

Pchejetski D, Nunes J, Sauer L, Sidhu J, Sharma A, Keun HC, Waxman J, Stebbing J. Pchejetski D, et al. Among authors: waxman j. Breast Cancer Res Treat. 2010 Nov;124(2):543-9. doi: 10.1007/s10549-010-0968-y. Epub 2010 Jun 10. Breast Cancer Res Treat. 2010. PMID: 20535545

6

Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel.

Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D. Sauer L, et al. Among authors: waxman j. Int J Cancer. 2009 Dec 1;125(11):2728-36. doi: 10.1002/ijc.24640. Int J Cancer. 2009. PMID: 19521959

7

Circulating nucleic acids as biomarkers of prostate cancer.

Sita-Lumsden A, Fletcher CE, Dart DA, Brooke GN, Waxman J, Bevan CL. Sita-Lumsden A, et al. Among authors: waxman j. Biomark Med. 2013 Dec;7(6):867-77. doi: 10.2217/bmm.13.104. Biomark Med. 2013. PMID: 24266819 Free PMC article. Review.

8

Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer.

Murillo-Garzón V, Gorroño-Etxebarria I, Åkerfelt M, Puustinen MC, Sistonen L, Nees M, Carton J, Waxman J, Kypta RM. Murillo-Garzón V, et al. Among authors: waxman j. Nat Commun. 2018 May 1;9(1):1747. doi: 10.1038/s41467-018-04042-w. Nat Commun. 2018. PMID: 29717114 Free PMC article.

9

Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147.

Rodriguez-Teja M, Gronau JH, Minamidate A, Darby S, Gaughan L, Robson C, Mauri F, Waxman J, Sturge J. Rodriguez-Teja M, et al. Among authors: waxman j. Mol Cancer Res. 2015 Mar;13(3):538-47. doi: 10.1158/1541-7786.MCR-14-0344-T. Epub 2014 Nov 7. Mol Cancer Res. 2015. PMID: 25381222

10

AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.

Rodriguez-Teja M, Gronau JH, Breit C, Zhang YZ, Minamidate A, Caley MP, McCarthy A, Cox TR, Erler JT, Gaughan L, Darby S, Robson C, Mauri F, Waxman J, Sturge J. Rodriguez-Teja M, et al. Among authors: waxman j. J Pathol. 2015 Mar;235(4):581-92. doi: 10.1002/path.4485. Epub 2014 Dec 24. J Pathol. 2015. PMID: 25408555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results